Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2006-03-28
2006-03-28
Guzo, David (Department: 1636)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C435S320100, C435S455000, C536S023100, C536S024100, C536S024500
Reexamination Certificate
active
07018984
ABSTRACT:
Embodiments of the present invention feature methods and compositions for controlling the translation of viral peptides and proteins from viral nucleic acid, with particular applications to pestivirus and HCV. The methods and compositions feature control elements of the 5′UT region of the viral genome.
REFERENCES:
patent: 4593002 (1986-06-01), Dulbecco
patent: 5350671 (1994-09-01), Houghton
patent: 6433159 (2002-08-01), Anderson
patent: 0 318 216 (1989-05-01), None
patent: 0 388 232 (1990-09-01), None
patent: 0 699 751 (1996-03-01), None
patent: WO 88/07544 (1988-10-01), None
patent: WO 91/14436 (1990-11-01), None
patent: WO 91/07092 (1991-05-01), None
patent: WO 91/16331 (1991-10-01), None
Buck et al. “Phosphate-Methylated DNA Aimed at HIV-1 RNA Loops and Integrated DNA Inhibits Viral Infectivity”, Science, vol. 248, 1990 pp. 208-212.
Han et al. “Characterization of theTerminal Regions of Hepatitis C Viral RNA: Identification of conserved sequences in the 5′ untranslated Region and poly(A) Tails at the 3′ end.”, PNAS, vol. 88, pp. 1711-1715, Mar.; 1991.
van der Krol et al. “Modulation of Eukaryotic Gene Expression by Complementary RNA or DNA Sequences”, vol. 6, No. 10, pp. 957-976, 1988.
Loose-Mitchell, “Antisense Nucleic Acids as a Potential class of Pharmaceutical Agents”, TIPS, Feb. 1988, vol. 9, pp. 45-47.
Inchauspe et al. “Genomic Structure of the Human Prototype Strain H of Hepatitis C Virus: Comparison with American and Japanese Isolates”, PNAS, vol. 88, pp. 10292-10296.
Letsinger et al. “Cholesteryl-conjugated oligonucleotides: Synthesis, Properties, and Activity as Inhibitors of Replication of Human Immunodeficiency Virus in Cell Culture”, PNAS, vol. 86, pp. 6553-6556, Sep. 1989.
Houghton et al. “Molecular Biology of the Hepatitis C Viruses: Implications for Diagnosis, Development and Control of Viral Disease”, Hepatology, vol. 14(2), Aug. 1991, pp. 381-388.
Choo et al. “Genetic Organization and Diversity of the Hepatitis C Virus”, PNAS, vol. 88, pp. 2451-2455, Mar. 1991.
Gura, Science, vol. 270, pp. 575-577, Oct. 27, 1995.
Nature Biotechnology, vol. 15, pp. 519-524.
Andrea D. Branch, TIBS, vol. 23, 99. 45-50.
Castelmann et al., Intervirology, 1997, vol. 40, pp. 394-399.
Alt et al., European Journal of Clinical Investigation, 1999, vol. 29, 99. 868-876.
Brown-Driver et al., Antisense Nucleic Acid Drug Development, 1999, vol. 9(2), pp. 145-154.
Buck et al., “Phosphate-methylated DNA aimed at HIV-1 RNA loops and integrated DNA inhibits viral infectivity,”Science,1990, 248, 208-212.
Choo et al, “Genetic organization and diversity of the hepatitis C virus,”Proc. Natl. Acad. Sci.,(USA), 1991, 88, 2451-2455.
Choo et al., “Isolation of a cDNA Clone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome,”Science,1989, 244, 359-362.
Dienstag, J.L., and Alter, H.J., “Non-A, non-B hepatitis: evolving epidemiologic and clinical perspective,”Seminars in Liver Disease,1986, 6, 67-81.
Edery et al., “Activation of double-stranded RNA-dependent kinase (dsl) by the TAR region of HIV-1 mRNA: a novel tranlational control mechanism,”Cell,1989, 56, 303-312.
Elroy-Stein et al., “Cap-dependent translation of mRNA conferred by encephalomyocarditis virus 5′ sequence improves the performance of vaccinia virus/bacteriophage T7 hybrid expression system,”Proc. Natl. Acad. Sci.(USA), 1989, 86, 6126-6130.
Federoval et al., “The influence of the target structure on the efficiency of alkylation of single-stranded DNA with the reactive derivatives of antisense oligonucleotides,”FEBS,1992, 302, 47-50.
Graessman et al., “Inhibition of SV40 gene expression by microinjected small antisense RNA and DNA molecules,”Nucl. Acid Research,1991, 19, 53-59.
Han et al., “Characterization of terminal regions of hepatitis C viral RNA: Identification of conserved sequences in the 5′ untranslated region and poly(A) tails at the 3′ end,”Proc. Natl. Acad. Sci.(USA), 1991, 88, 1711-1715.
Houghton et al., “Molecular biology of the hepatitis C viruses: implicatins for diagnosis, development and control of viral disease,”Hepatology,1991, 14, 381-388.
Hu et al., “Slot hybridization to detect circulating HCV RNA using a cDNA probe from the 5′ non-coding region of the HCV genome,” Third International Symposium on HCV (Program and Abstracts) Strasbourg, France, 1991.
Inchauspe et al., “Genomic structure of the human prototype strain H of hepatitis C virus: comparison with American and Japanes isolates,”Proc. Natl. Acad. Sci.(USA), 1991, 88, 10292-10296.
Jang et al., “Initiation of protein synthesis by internal entry of ribosomes in the 5′ nontranslated region of Encephalomyocarditis virus RNA In vivo,”J. Virol.,1989, 63, 1651-1660.
Jobling and Gehrke, “Enhanced translation of chimaeric messenger RNAs containing a plant viral untranslated leader sequence,”Nature,1987, 325, 622-625.
Kato et al., “Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis,”Proc. Natl. Acad. Sci.(USA), 1990, 87, 9524-9528.
Kozak et al., “Comparison of initiation of protein synthesis in prokaryotes, eukaryotes, and organells,”Microbiol. Rev.,1983, 47, 1-45.
Kozak et al., “Influence of mRNA secondary structure on initiation by eukarotic ribosomes,”Proc.Natl. Acad. Sci.(USA). 1986, 83, 2850-2854.
Kozak et al., “The scanning model for translation: An update,”J. Cell Biol.,1989, 108, 229-241.
Macejak, D.G. and Sarnow, P., “Internal initiation of translation mediated by the 5′ leader of a celular mRNA,”Nature,1991, 353, 90-94.
Okamoto et al, “Nucleotide Sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: comparison with reported isolates for conserved and divergent regions,”J. Gen. Virol.,1991, 72, 2697-2704.
Pelletier, J. and Sonenberg N., “Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA,”Nature,1988, 334, 320-325.
Shyamala, V. and Ames, G.F., “Use of exonuclease for rapid polymerase chain reaciton basedIn vitromutagenesis,”Gene,1991, 97, 1-6.
Shyamala V. et al., “Genome walking by singel-specific rimer polymerase chain reaction: SSP-PCR,”Gene,1989, 84, 1-8.
Shyamalia et al., “Tranlation Control by the 5′ Untranslated Region of HCV RNA,” Third International Symposium on HCV (Program and Abstracts) Strasbourg France, 1991.
Straus, E. and Strauss, J.H., “Structure and Replication of the Alphavirus Genome,” inThe Togaviridae and Flaviviridae,S. Schleslinger and M.J. Schlesinger (Eds.), Plenum, NY, 1986, 35-90.
Takamizawa et al., “Structure and organization of the hepatitis C virus genome isolted from human carriers,”J. Virol.,1991, 65, 1105-1113.
Weiner et al., “Detection of hepatitis C viral sequences in non-A, non-B hepatitis,”Lancet,1990, 355(8680), 1-3.
Adam et al., “Internal initiation of translation in retroviral vectors carrying picornavirus 5′ nontranslated regions,”J. Virol.,1991, 65(9), 4985-4990.
Blight et al., “Detection of hepatitis C virus RNA byin situhybridization”,Liver,1992, 12(4 pt. 2), 286-289.
Chen et al., “Supercoil sequencing: a fast and simple method for sequencing plasmid DNA,”DNA,1985, 4(2), 165-170.
Chen et al., “The Taiwanese Hepatitis C Virus Genome: Sequence Determination and Mapping the 5′ Termini of Viral Genomic and Antigenomic RNA”,Virology,1992, 188(1), 102-113.
Egholm et al., “Peptide Nucleic Acids (PNA). Oligonucleotide Analogues with an Achiral Peptide Backbone”,JACS,1992, 114, 1895-1897.
Eibl et al., “Electrostatic Interactions at Charged Li
Han Jang H.
Houghton Michael
Selby Mark J.
Spaete Richard R.
Suh Byung S.
Chiron Corporation
Guzo David
Harbin Alisa A.
Holmes-Son Michelle
Moran Michael J.
LandOfFree
Methods and compositions for controlling translation of HCV... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for controlling translation of HCV..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for controlling translation of HCV... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3585943